v3.26.1
SHARE-BASED COMPENSATION PLAN - Restricted shares plan (Details)
 12 Months Ended
Dec. 31, 2025
BRL (R$)
shares
shares
Dec. 31, 2023
BRL (R$)
Dec. 31, 2024
BRL (R$)
shares
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Non-current provisions for employee benefits | R$ R$ 332,322,000   R$ 361,974,000
Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of other equity instruments outstanding in share-based payment arrangement 3,076,116   2,980,111
Shares granted 563,980    
Restricted stock, year two 504,946    
Restricted stock, year three 431,331    
Restricted stock, year four 230,773    
Restricted Stock, Year Five 1,672,574    
Restricted Stock, Year Six 236,492    
Non-current provisions for employee benefits | R$ R$ 80,742,000 R$ 26,744,000 R$ 60,226,000
Increase Provision Share Based Payment | R$ 45,642,000 81,276,000  
Decrease Provision Share Based Payment | R$ R$ (25,126,000) R$ (47,794,000)  
Grant Year 2022 | Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Fair value on grant date | R$     R$ 53.81
Number of other equity instruments outstanding in share-based payment arrangement   115,800
Shares granted 3,758    
Restricted stock, year two    
Restricted stock, year three    
Restricted Stock, Year Six    
Grant Year 2023 | Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Fair value on grant date | R$     R$ 51.41
Number of other equity instruments outstanding in share-based payment arrangement 396,016   383,568
Shares granted 12,448    
Restricted stock, year two 277,249    
Restricted stock, year three 118,767    
Restricted Stock, Year Six    
Grant Year 2024 | Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Fair value on grant date | R$     R$ 55.77
Number of other equity instruments outstanding in share-based payment arrangement 2,212,835   2,480,743
Shares granted 80,509    
Restricted stock, year two 227,697    
Restricted stock, year three 312,564    
Restricted Stock, Year Five 1,672,574    
Restricted Stock, Year Six    
Grant Year 2025 | Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Fair value on grant date | R$     R$ 61.39
Number of other equity instruments outstanding in share-based payment arrangement 467,265    
Shares granted 467,265    
Restricted stock, year four 230,773    
Restricted Stock, Year Six 236,492